<DOC>
	<DOCNO>NCT01880125</DOCNO>
	<brief_summary>1 . Objective : To evaluate pharmacokinetic profile SR 75 mg tramadol/650 mg acetaminophen formulation compare immediate release ( IR ) 37.5 mg tramadol/325 mg acetaminophen formulation single dose steady state 2 . Subjects : Healthy subject 3 . Methods : A phase I study evaluate pharmacokinetic sustain release immediate release treatment profile steady state .</brief_summary>
	<brief_title>Assessment Pharmacokinetics Sustained Release Formulation Tramadol/Acetaminophen Combination</brief_title>
	<detailed_description>This study open , randomize , 2-period , 2-treatment multiple-dose crossover study immediate release treatment sustain release treatment design assess pharmacokinetics 2-day repeated administration steady state achieve .</detailed_description>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Subjects age 20 45 year Subjects weigh ≥ 45 kg within 20 % ideal body weight No clinically relevant abnormality identify vital sign measurement , 12lead electrocardiography routine laboratory test Hypersensitivity histories sensitivity either tramadol acetaminophen Evidence history clinically significant renal , digestive , respiratory , musculoskeletal , endocrine , psychiatric , neurological , hematological cardiovascular disease Taking prescription herbal medicine within 2 week study overthecounter medication within 1 week study Systolic blood pressure ( SBP ) ≥ 160 mmHg ≤ 100 mmHg diastolic blood pressure ( DBP ) ≥ 95 mmHg ≤ 60 mmHg Any surgical medical condition could affect drug absorption</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Tramadol</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Sustained release</keyword>
	<keyword>Immediate release</keyword>
</DOC>